224.98
0.52%
-1.17
Dopo l'orario di chiusura:
224.98
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$226.15
Aprire:
$226.64
Volume 24 ore:
786.98K
Capitalizzazione di mercato:
$64.32B
Reddito:
$15.32B
Utile/perdita netta:
$1.37B
Rapporto P/E:
52.20
EPS:
4.31
Flusso di cassa netto:
$1.64B
1 W Prestazione:
+1.90%
1M Prestazione:
-1.29%
6M Prestazione:
+34.55%
1 anno Prestazione:
+33.30%
Ecolab, Inc. Stock (ECL) Company Profile
Nome
Ecolab, Inc.
Settore
Industria
Telefono
800-232-6522
Indirizzo
1 Ecolab Place, St. Paul, MN
Ecolab, Inc. Stock (ECL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-02-14 | Downgrade | JP Morgan | Overweight → Neutral |
2024-01-16 | Aggiornamento | BofA Securities | Underperform → Neutral |
2024-01-08 | Downgrade | Seaport Research Partners | Buy → Neutral |
2023-11-30 | Iniziato | Raymond James | Outperform |
2023-09-01 | Iniziato | Berenberg | Hold |
2023-07-05 | Downgrade | Northcoast | Buy → Neutral |
2023-06-14 | Iniziato | Citigroup | Neutral |
2023-04-17 | Downgrade | BofA Securities | Neutral → Underperform |
2023-02-15 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2022-12-02 | Downgrade | Barclays | Overweight → Equal Weight |
2022-11-02 | Downgrade | Deutsche Bank | Buy → Hold |
2022-10-13 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
2022-09-06 | Aggiornamento | Northcoast | Neutral → Buy |
2022-07-15 | Iniziato | Northcoast | Neutral |
2022-07-13 | Downgrade | BofA Securities | Buy → Neutral |
2022-07-13 | Iniziato | Wells Fargo | Overweight |
2022-06-03 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
2022-05-20 | Ripresa | Credit Suisse | Neutral |
2022-04-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
2022-04-05 | Iniziato | Atlantic Equities | Overweight |
2022-03-22 | Aggiornamento | BofA Securities | Neutral → Buy |
2022-03-17 | Aggiornamento | Edward Jones | Hold → Buy |
2022-02-16 | Aggiornamento | JP Morgan | Underweight → Neutral |
2022-02-15 | Downgrade | Boenning & Scattergood | Outperform → Neutral |
2022-01-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2021-12-03 | Ripresa | Evercore ISI | In-line |
2021-10-27 | Downgrade | JP Morgan | Neutral → Underweight |
2021-10-13 | Iniziato | Mizuho | Neutral |
2021-09-27 | Iniziato | Vertical Research | Hold |
2021-09-03 | Ripresa | RBC Capital Mkts | Outperform |
2021-08-16 | Downgrade | Evercore ISI | Outperform → In-line |
2021-04-28 | Aggiornamento | JP Morgan | Underweight → Neutral |
2021-03-30 | Aggiornamento | Deutsche Bank | Hold → Buy |
2021-03-29 | Ripresa | Credit Suisse | Neutral |
2021-03-15 | Ripresa | Credit Suisse | Neutral |
2021-01-15 | Aggiornamento | Gabelli & Co | Hold → Buy |
2020-09-22 | Iniziato | Evercore ISI | Outperform |
2020-07-28 | Aggiornamento | Boenning & Scattergood | Neutral → Outperform |
2020-07-08 | Ripresa | BofA Securities | Neutral |
2020-06-03 | Downgrade | Gabelli & Co | Buy → Hold |
2020-03-17 | Downgrade | JP Morgan | Neutral → Underweight |
2020-02-07 | Downgrade | Boenning & Scattergood | Outperform → Neutral |
2019-05-01 | Reiterato | BofA/Merrill | Buy |
2019-04-18 | Downgrade | UBS | Buy → Neutral |
2019-02-20 | Downgrade | JP Morgan | Overweight → Neutral |
2018-10-31 | Aggiornamento | JP Morgan | Neutral → Overweight |
2018-10-23 | Ripresa | BofA/Merrill | Buy |
2018-06-22 | Downgrade | JP Morgan | Neutral → Underweight |
2018-05-02 | Downgrade | JP Morgan | Overweight → Neutral |
2018-01-24 | Reiterato | Stifel | Hold |
2018-01-05 | Downgrade | Citigroup | Buy → Neutral |
2017-11-07 | Reiterato | RBC Capital Mkts | Outperform |
2017-09-12 | Reiterato | RBC Capital Mkts | Outperform |
2017-08-15 | Iniziato | Morgan Stanley | Equal-Weight |
2017-08-02 | Reiterato | UBS | Buy |
2017-05-26 | Aggiornamento | JP Morgan | Neutral → Overweight |
Mostra tutto
Ecolab, Inc. Borsa (ECL) Ultime notizie
Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises
Zacks Investment Research
Here's Why Ecolab (ECL) is a Strong Growth Stock
Zacks Investment Research
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks Investment Research
Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now
Zacks Investment Research
GE HealthCare (GEHC) Q1 Earnings In Line, Sales Volume Decline
Zacks Investment Research
Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
Zacks Investment Research
Ecolab, Inc. Azioni (ECL) Dati Finanziari
Ecolab, Inc. (ECL) Reddito 2024
ECL ha riportato un ricavo (TTM) di $15.32 miliardi per il trimestre terminato il 2023-12-31, un +7.98% salita anno su anno.
Ecolab, Inc. (ECL) Reddito netto 2024
ECL l'utile netto (TTM) è stato di $1.37 miliardi per il trimestre terminato il 2023-12-31, un +25.70% aumento anno su anno.
Ecolab, Inc. (ECL) Flusso di cassa 2024
ECL ha registrato un flusso di cassa disponibile (TTM) di $1.64 miliardi per il trimestre conclusosi con 2023-12-31, un +52.19% aumento anno su anno.
Ecolab, Inc. (ECL) Utile per azione 2024
L'utile per azione (TTM) di ECL è stato pari a $4.79 per il trimestre terminato il 2023-12-31, un +25.39% crescita anno su anno.
Ecolab, Inc. Azioni (ECL) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Busch Angela M | EVP - CORP STRAT & BUS DEV |
Mar 15 '24 |
Option Exercise |
107.69 |
6,118 |
658,817 |
21,272 |
Vautrinot Suzanne M | Director |
Mar 15 '24 |
Option Exercise |
104.85 |
2,900 |
304,065 |
9,895 |
LARSON MICHAEL | Director |
Mar 14 '24 |
Option Exercise |
104.85 |
2,400 |
251,640 |
16,117 |
Bradway Jennifer J | SVP & CORPORATE CONTROLLER |
Feb 15 '24 |
Option Exercise |
107.69 |
1,122 |
120,823 |
3,973 |
Bradway Jennifer J | SVP & CORPORATE CONTROLLER |
Feb 15 '24 |
Sale |
216.01 |
944 |
203,913 |
3,029 |
Cook Gregory B | EVP & PRES - INST GROUP |
Feb 01 '24 |
Option Exercise |
119.12 |
1,500 |
178,680 |
9,054 |
ZILLMER JOHN J | Director |
Jan 10 '24 |
Option Exercise |
104.85 |
2,400 |
251,640 |
46,221 |
Marsh Laurie M | EVP - HUMAN RESOURCES |
Dec 04 '23 |
Option Exercise |
117.73 |
11,917 |
1,402,988 |
32,455 |
Marsh Laurie M | EVP - HUMAN RESOURCES |
Dec 04 '23 |
Sale |
191.41 |
11,917 |
2,281,081 |
20,538 |
Kirkland Scott D | CHIEF FINANCIAL OFFICER |
Dec 03 '23 |
Option Exercise |
0.00 |
2,482 |
0 |
7,489 |
Capitalizzazione:
|
Volume (24 ore):